Dartmouth researchers are developing a new treatment for MRSA infections, reports VPR.
Karl Griswold, an associate professor of engineering at Thayer School of Engineering, and Chris Bailey-Kellogg, a professor of computer science, have redesigned the protein lysostaphin to allow the body to use it to fight the infection, explains VPR.
“We’re changing the attacker,” Griswold tells VPR. “We’re changing the molecule, lysostaphin, so that the red flags that it waves to the human immune system are suppressed, so the human immune system lets the molecule work in the body. We want to make a stealth version of lysostaphin.”
Listen to the full story, broadcast 5/28/15 on VPR.